Back to Awarded Treatment Trials
Awarded Trial: 14T-005
Grant ID
14T-005
Illness
Bipolar disorder
Primary Drug/Intervention
Ebselen
Primary Dosage
600 mg twice daily
Secondary Drug Intervention
antipsychotic drug treatment
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Cowen
Sample Size
60
Duration of Study Period for Each Subject
42 days
Outcome Measurements
N/A
Results
N/A
Publication
Psychopharmacology September 2020
Link
https://doi.org/10.1007/s00213-020-05654-1
PI Name
Philip Cowen
Degree
MD
Center
Warneford Hospital
Institution
University of Oxford
Address
Neurosciences Building, Warneford Hospital, University of Oxford
City or Town
Oxford
State or Province
United Kingdom
Zip or Postal Code
OX3 7JX
Country
United Kingdom
Email Address
phil.cowen@psych.ox.ac.uk